What is SouthEastern Pathology?
With a legacy spanning over five decades, SouthEastern Pathology, P.C. serves as a cornerstone of medical diagnostics in Northwest Georgia. The organization is distinguished by its accreditation from the College of American Pathologists, a testament to its adherence to stringent global standards in laboratory quality assurance. By providing essential pathology services to both physicians and patients, the company bridges the gap between complex clinical testing and accessible patient care. Their operational framework includes sophisticated digital integration, such as online bill payment and secure access to test results, which streamlines the patient experience while maintaining the high-fidelity data integrity required in modern medicine.
How much funding has SouthEastern Pathology raised?
SouthEastern Pathology has raised a total of $890K across 2 funding rounds:
Debt
$350K
Debt
$540K
Debt (2020): $350K with participation from PPP
Debt (2021): $540K led by PPP
Key Investors in SouthEastern Pathology
PPP
Public-Private Partnership
What's next for SouthEastern Pathology?
Looking ahead, the strategic deployment of the $540K capital is expected to focus on the modernization of laboratory facilities and the potential integration of advanced diagnostic technologies. As the company navigates the complexities of the enterprise healthcare sector, the focus will likely remain on optimizing operational efficiency and expanding its diagnostic capabilities to meet the evolving needs of the medical community. By prioritizing technological upgrades and maintaining its accredited status, SouthEastern Pathology is poised to reinforce its role as a primary provider of reliable pathology services, ensuring long-term sustainability and growth in an increasingly data-driven healthcare environment.
See full SouthEastern Pathology company page
